Banco Santander (Brasil) (BSBR) officer reports holding 25,524 UNIT - SANB11
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Banco Santander (Brasil) S.A. officer Aleixo Marcelo filed an initial ownership report showing his holdings in the company. The Form 3 lists direct ownership of 25,524 units of "UNIT - SANB11" following the reported position, establishing a baseline of his equity stake as an officer.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Aleixo Marcelo
Role
Officer w/o Specific Desig
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | UNIT - SANB11 | -- | -- | -- |
Holdings After Transaction:
UNIT - SANB11 — 25,524 shares (Direct)
Footnotes (1)
FAQ
What does Aleixo Marcelo’s Form 3 filing for BSBR disclose?
The Form 3 filing discloses that officer Aleixo Marcelo directly holds 25,524 units of "UNIT - SANB11" in Banco Santander (Brasil) S.A., establishing his initial reported equity position as a company insider.
Is the BSBR Form 3 for Aleixo Marcelo a buy or sell transaction?
The BSBR Form 3 for Aleixo Marcelo does not report a buy or sell transaction. It is an initial ownership statement listing his existing holdings of 25,524 units of "UNIT - SANB11" held directly.
How many Banco Santander (Brasil) UNIT - SANB11 does Aleixo Marcelo hold?
The filing shows that Aleixo Marcelo directly holds 25,524 units of "UNIT - SANB11" of Banco Santander (Brasil) S.A., as his total stake following the reported ownership entry.
What is the ownership type reported for Aleixo Marcelo’s BSBR holdings?
The Form 3 states that Aleixo Marcelo holds his 25,524 units of "UNIT - SANB11" as direct ownership, meaning the position is recorded in his own name rather than through an intermediary entity.
Does the BSBR Form 3 include any derivative securities for Aleixo Marcelo?
The Form 3 data shows no listed derivative securities for Aleixo Marcelo. Only a holding of 25,524 units of "UNIT - SANB11" is reported, with no options, warrants, or other derivatives disclosed in the derivative section.